Abstract
The emerging insights into kinase function and evolution combined with a rapidly growing number of crystal structures of protein kinases complexes have facilitated a comprehensive structural bioinformatics analysis of sequence–structure relationships in determining the binding function of protein tyrosine kinases. We have found that evolutionary signal derived solely from the tyrosine kinase sequence conservation can not be readily translated into the ligand binding phenotype. However, fingerprinting ligand–protein interactions using in silico profiling of inhibitor binding against protein tyrosine kinases crystal structures can detect a functionally relevant kinase binding signal and reconcile the existing experimental data. In silico proteomics analysis unravels mechanisms by which structural plasticity of the tyrosine kinases is linked with the conformational preferences of cancer drugs Imatinib and Dasatinib in achieving effective drug binding with a distinct spectrum of the tyrosine kinome. While Imatinib binding is highly sensitive to the activation state of the enzyme, the computed binding profile of Dasatinib is remarkably tolerant to the conformational state of ABL. A comprehensive study of evolutionary, structural, dynamic and energetic aspects of tyrosine kinases binding with clinically important class of inhibitors provides important insights into mechanisms of sequence–structure relationships in the kinome space and molecular basis of functional adaptability towards specific binding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hunter, T., Plowman, G.D.: The protein kinases of budding yeast: six score and more. Trends Biochem. Sci. 22, 18–22 (1997)
Manning, G., Whyte, D.B., Martinez, R., Hunter, T., Sudarsanam, S.: The protein kinase complement of the human genome. Science 298, 1912–1934 (2002)
Bain, J., McLauchlan, H., Elliott, M., Cohen, P.: The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199–204 (2003)
Vulpetti, A., Bosotti, R.: Sequence and structural analysis of kinase ATP pocket residues. Il Farmaco 59, 759–765 (2004)
Wong, S., Witte, O.N.: The BCR-ABL story: bench to bedside and back. Annu. Rev. Immunol. 22, 247–306 (2004)
Huse, M., Kuriyan, J.: The conformational plasticity of protein kinases. Cell 109, 226–282 (2002)
Schindler, T., Bornmann, W., Pellicena, P., Miller, W.T., Clarkson, B., Kuriyan, J.: Structural mechanism for Imatinib mesylate inhibition of abelson tyrosine kinase. Science 289, 1938–1942 (2000)
Tokarski, J.S., Newitt, J.A., Chang, C.Y., Cheng, J.D., Wittekind, M., Kiefer, S.E., Kish, K., Lee, F.Y., Borzillerri, R., Lombardo, L.J., Xie, D., Zhang, Y., Klei, H.: The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants. Cancer Res., 66, 5790–5797 (2006)
Levinson, N.M., Kuchment, O., Shen, K., Young, M.A., Koldobskiy, M., Karplus, M., Cole, P.A., Kuriyan, J.: A SRC-like inactive conformation in the ABL tyrosine kinase domain. PLoS Biol. 4, 753–767 (2006)
Verkhivker, G.M.: Imprint of evolutionary conservation and protein structure variation on the binding function of protein tyrosine kinases. Bioinformatics 22, 1846–1854 (2006)
Felsenstein, J.: PHYLIP: Phylogeny Inference Package, Version 3.6., Seattle, WA University of Washington (2002)
Mayo, S.L., Olafson, B.D., Goddard III, W.A.: DREIDING: a generic force field for molecular simulation. J. Phys. Chem. 94, 8897–8909 (1990)
Sugita, Y., Okamoto, Y.: Replica-exchange molecular dynamics method for protein folding. Chem. Phys. Lett. 314, 141–151 (1999)
Fabian, M.A., Biggs III, W.H., Treiber, D.K., Atteridge, C.E., Azimioara, M.D., Benedetti, M.G., Carter, T.A., Ciceri, P., Edeen, P.T., Floyd, M., Ford, J.M., Galvin, M., Gerlach, J.L., Grotzfeld, R.M., Herrgard, S., Insko, D.E., Insko, M.A., Lai, A.G., Lelias, J.M., Mehta, S.A., Milanov, Z.V., Velasco, A.M., Wodicka, L.M., Patel, H.K., Zarrinkar, P.P., Lockhart, D.J.: A small molecule-kinase interaction map for clinical kinase inhibitors. Nature Biotech. 23, 329–336 (2005)
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Verkhivker, G.M. (2007). Computational Proteomics of Biomolecular Interactions in Sequence and Structure Space of the Tyrosine Kinome: Evolutionary Constraints and Protein Conformational Selection Determine Binding Signatures of Cancer Drugs. In: Masulli, F., Mitra, S., Pasi, G. (eds) Applications of Fuzzy Sets Theory. WILF 2007. Lecture Notes in Computer Science(), vol 4578. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73400-0_77
Download citation
DOI: https://doi.org/10.1007/978-3-540-73400-0_77
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-73399-7
Online ISBN: 978-3-540-73400-0
eBook Packages: Computer ScienceComputer Science (R0)